Experimental Support for the Possibility of Retrograde Genesis of Intraductal Carcinoma of the Prostate
International Journal of Surgical Pathology · 2023-04 · 31 (2) · 184-189
DOI: 10.1177/10668969221098080 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Surgical Pathology, online erschienen am 06.05.2022. Verfasst von Oleksandr N Kryvenko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Prostatic Intraepithelial Neoplasia, Prostatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
Historically, intraductal carcinoma of the prostate (IDC-P) was postulated to be a retrograde spread of high-grade invasive prostate cancer. There is evidence that IDC-P can primarily originate in the prostatic ducts. The retrograde genesis has never been experimentally or clinically confirmed before.
Methods
Biopsy proven intermediate or high-risk prostate cancer was orthotopically grafted in the prostate of severe combined immunodeficiency gamma mice. Cancer growth was monitored by serum PSA levels. The animals were sacrificed and grafted areas were histological examined.
Results
Twenty-one of 23 mice survived and demonstrated rising serum PSA. In 10 of 21 animals, human prostate cancer was identified orthotopically. Except for one case where the human biopsy showed a Grade Group 2 prostate cancer and mouse graft was Grade Group 5, other 9 specimens showed comparable grades. One of the specimens demonstrated a cribriform invasive prostate cancer and adjacent IDC-P.
Conclusion
These experimental data offer some evidence that invasive prostate cancer can demonstrate a retrograde spread in the prostatic ducts as IDC-P. Its ability to primarily arise in the ducts has been demonstrated in other studies. However, the issue which remains unresolved is in its most common presentation of IDC-P intermixed with high-grade invasive cancer if it is the former or the latter which came first. Possibly resolving this dilemma will shed some light on the existing controversies if IDC-P should or should not be graded when invasive cancer is present.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
- Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
- Department Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA.
- Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
ORCID-Profile: Oleksandr N Kryvenko
Zitieren
APA
Kryvenko, O. N., Punnen, S., Udayakumar, T. S., Gaston, S. M., Tao, W., Ma, W., Stoyanova, R., & Pollack, A. (2023). Experimental Support for the Possibility of Retrograde Genesis of Intraductal Carcinoma of the Prostate. International Journal of Surgical Pathology, 31(2), 184-189. https://doi.org/10.1177/10668969221098080
Vancouver
Kryvenko ON, Punnen S, Udayakumar TS, Gaston SM, Tao W, Ma W, et al. Experimental Support for the Possibility of Retrograde Genesis of Intraductal Carcinoma of the Prostate. International Journal of Surgical Pathology. 2023;31(2):184-189. doi:10.1177/10668969221098080
BibTeX
@article{Kryvenko2023,
author = {Kryvenko, Oleksandr N and Punnen, Sanoj and Udayakumar, Thirupandiyur S and Gaston, Sandra M and Tao, Wensi and Ma, Wendi and Stoyanova, Radka and Pollack, Alan},
title = {Experimental Support for the Possibility of Retrograde Genesis of Intraductal Carcinoma of the Prostate},
journal = {International Journal of Surgical Pathology},
year = {2023},
volume = {31},
number = {2},
pages = {184--189},
doi = {10.1177/10668969221098080}
}
EUVIMED